|
Volumn 76, Issue SPEC. ISS. 1, 2003, Pages
|
Angiogenesis imaging in the post-genomic era
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
BIOLOGICAL MARKER;
IBRITUMOMAB TIUXETAN;
INDIUM 111;
NANOPARTICLE;
YTTRIUM 90;
ANGIOGENESIS;
B CELL LYMPHOMA;
COLORECTAL CANCER;
COMPUTER ASSISTED TOMOGRAPHY;
CONTRAST ENHANCEMENT;
DIAGNOSTIC IMAGING;
DOSIMETRY;
DRUG APPROVAL;
DRUG DELIVERY SYSTEM;
EDITORIAL;
FOLLICULAR LYMPHOMA;
GENE EXPRESSION;
GENOMICS;
HIGH THROUGHPUT SCREENING;
HUMAN;
IMAGE ANALYSIS;
IMAGE DISPLAY;
IMAGING SYSTEM;
INDIVIDUALIZATION;
ISOTOPE LABELING;
METASTASIS;
MOLECULAR GENETICS;
NEOVASCULARIZATION (PATHOLOGY);
NON INVASIVE MEASUREMENT;
NONHODGKIN LYMPHOMA;
PHENOTYPE;
POSITRON EMISSION TOMOGRAPHY;
PROTEIN EXPRESSION;
PROTEOMICS;
QUANTITATIVE ANALYSIS;
BIOLOGICAL MARKERS;
DIAGNOSTIC IMAGING;
HUMANS;
NEOVASCULARIZATION, PATHOLOGIC;
|
EID: 8844265991
PISSN: 00071285
EISSN: None
Source Type: Journal
DOI: 10.1259/bjr/34932557 Document Type: Editorial |
Times cited : (3)
|
References (6)
|